<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://new.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 28 Oct 2026 07:00:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://new.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Nexus Gold Applies For 14,151 Hectares in Colombia&amp;apos;s South Bolívar Gold District</title>
   <link>http://www.streetinsider.com/Press+Releases/Nexus+Gold+Applies+For+14%2C151+Hectares+in+Colombia%26apos%3Bs+South+Bol%C3%ADvar+Gold+District/27244522.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;VANCOUVER, British Columbia, Oct.  28, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;Nexus Gold Corp. (TSXV: NXS; OTC: NXSGF) (“Nexus” or the “Company”)&lt;/strong&gt; is pleased to announce that it has submitted eight mineral concession applications covering approximately &lt;strong&gt;14,151 hectares (141.5 km²)&lt;/strong&gt; in the South Bolívar gold district of Colombia (see Figure 1 below). The applications support Nexus’ strategy of combining exploration of prospective Colombian ground with evaluation of advanced gold projects offering a potential pathway to production.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Located approximately 8 kilometres northwest of Santa Rosa del Sur, Bolívar, the application areas lie within the historic Serranía de San</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Nexus+Gold+Applies+For+14%2C151+Hectares+in+Colombia%26apos%3Bs+South+Bol%C3%ADvar+Gold+District/27244522.html</guid>
   <pubDate>Wed, 28 Oct 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXXGF</category>
   	  </item>
  <item>
   <title>Nexus Gold Applies For 14,151 Hectares in Colombia&amp;apos;s South Bolívar Gold District</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Nexus+Gold+Applies+For+14%2C151+Hectares+in+Colombia%26apos%3Bs+South+Bol%C3%ADvar+Gold+District/27244522.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;VANCOUVER, British Columbia, Oct.  28, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;Nexus Gold Corp. (TSXV: NXS; OTC: NXSGF) (“Nexus” or the “Company”)&lt;/strong&gt; is pleased to announce that it has submitted eight mineral concession applications covering approximately &lt;strong&gt;14,151 hectares (141.5 km²)&lt;/strong&gt; in the South Bolívar gold district of Colombia (see Figure 1 below). The applications support Nexus’ strategy of combining exploration of prospective Colombian ground with evaluation of advanced gold projects offering a potential pathway to production.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Located approximately 8 kilometres northwest of Santa Rosa del Sur, Bolívar, the application areas lie within the historic Serranía de San</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Nexus+Gold+Applies+For+14%2C151+Hectares+in+Colombia%26apos%3Bs+South+Bol%C3%ADvar+Gold+District/27244522.html</guid>
   <pubDate>Wed, 28 Oct 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXXGF</category>
   	  </item>
  <item>
   <title>Nexus Gold Applies For 14,151 Hectares in Colombia&amp;apos;s South Bolívar Gold District</title>
   <link>http://www.streetinsider.com/Press+Releases/Nexus+Gold+Applies+For+14%2C151+Hectares+in+Colombia%26apos%3Bs+South+Bol%C3%ADvar+Gold+District/27244522.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;VANCOUVER, British Columbia, Oct.  28, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;Nexus Gold Corp. (TSXV: NXS; OTC: NXSGF) (“Nexus” or the “Company”)&lt;/strong&gt; is pleased to announce that it has submitted eight mineral concession applications covering approximately &lt;strong&gt;14,151 hectares (141.5 km²)&lt;/strong&gt; in the South Bolívar gold district of Colombia (see Figure 1 below). The applications support Nexus’ strategy of combining exploration of prospective Colombian ground with evaluation of advanced gold projects offering a potential pathway to production.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Located approximately 8 kilometres northwest of Santa Rosa del Sur, Bolívar, the application areas lie within the historic Serranía de San</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Nexus+Gold+Applies+For+14%2C151+Hectares+in+Colombia%26apos%3Bs+South+Bol%C3%ADvar+Gold+District/27244522.html</guid>
   <pubDate>Wed, 28 Oct 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXXGF</category>
   	  </item>
  <item>
   <title>Nexus Gold Applies For 14,151 Hectares in Colombia&amp;apos;s South Bolívar Gold District</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Nexus+Gold+Applies+For+14%2C151+Hectares+in+Colombia%26apos%3Bs+South+Bol%C3%ADvar+Gold+District/27244522.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;VANCOUVER, British Columbia, Oct.  28, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;Nexus Gold Corp. (TSXV: NXS; OTC: NXSGF) (“Nexus” or the “Company”)&lt;/strong&gt; is pleased to announce that it has submitted eight mineral concession applications covering approximately &lt;strong&gt;14,151 hectares (141.5 km²)&lt;/strong&gt; in the South Bolívar gold district of Colombia (see Figure 1 below). The applications support Nexus’ strategy of combining exploration of prospective Colombian ground with evaluation of advanced gold projects offering a potential pathway to production.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Located approximately 8 kilometres northwest of Santa Rosa del Sur, Bolívar, the application areas lie within the historic Serranía de San</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Nexus+Gold+Applies+For+14%2C151+Hectares+in+Colombia%26apos%3Bs+South+Bol%C3%ADvar+Gold+District/27244522.html</guid>
   <pubDate>Wed, 28 Oct 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXXGF</category>
   	  </item>
  <item>
   <title>Form  D          Next Science Ltd                     </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++D++++++++++Next+Science+Ltd+++++++++++++++++++++/22193751.html</link>
   <description>si-local-file:///var/storage/secattach/20230925/22193751.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++D++++++++++Next+Science+Ltd+++++++++++++++++++++/22193751.html</guid>
   <pubDate>Mon, 25 Sep 2023 09:08:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXSCF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36841672</category>
   	  </item>
  <item>
   <title>Form  D          Next Science Ltd                     </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++D++++++++++Next+Science+Ltd+++++++++++++++++++++/22193751.html</link>
   <description>si-local-file:///var/storage/secattach/20230925/22193751.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++D++++++++++Next+Science+Ltd+++++++++++++++++++++/22193751.html</guid>
   <pubDate>Mon, 25 Sep 2023 09:08:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXSCF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36841672</category>
   	  </item>
  <item>
   <title>Form  D          Next Science Ltd                     </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++D++++++++++Next+Science+Ltd+++++++++++++++++++++/22193751.html</link>
   <description>si-local-file:///var/storage/secattach/20230925/22193751.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++D++++++++++Next+Science+Ltd+++++++++++++++++++++/22193751.html</guid>
   <pubDate>Mon, 25 Sep 2023 09:08:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXSCF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36841672</category>
   	  </item>
  <item>
   <title>New Study Finds XPERIENCE™ No Rinse Solution Has Persistent Efficacy Against Both Planktonic Bacteria and Bacterial Biofilms</title>
   <link>http://www.streetinsider.com/Press+Releases/New+Study+Finds+XPERIENCE%E2%84%A2+No+Rinse+Solution+Has+Persistent+Efficacy+Against+Both+Planktonic+Bacteria+and+Bacterial+Biofilms/20046281.html</link>
   <description>si-local-file:///var/storage/newsbody/2022/0510/20046281.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/New+Study+Finds+XPERIENCE%E2%84%A2+No+Rinse+Solution+Has+Persistent+Efficacy+Against+Both+Planktonic+Bacteria+and+Bacterial+Biofilms/20046281.html</guid>
   <pubDate>Tue, 10 May 2022 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36841672</category>
   	  </item>
  <item>
   <title>New Study Finds XPERIENCE™ No Rinse Solution Has Persistent Efficacy Against Both Planktonic Bacteria and Bacterial Biofilms</title>
   <link>http://www.streetinsider.com/Business+Wire/New+Study+Finds+XPERIENCE%E2%84%A2+No+Rinse+Solution+Has+Persistent+Efficacy+Against+Both+Planktonic+Bacteria+and+Bacterial+Biofilms/20046281.html</link>
   <description>si-local-file:///var/storage/newsbody/2022/0510/20046281.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/New+Study+Finds+XPERIENCE%E2%84%A2+No+Rinse+Solution+Has+Persistent+Efficacy+Against+Both+Planktonic+Bacteria+and+Bacterial+Biofilms/20046281.html</guid>
   <pubDate>Tue, 10 May 2022 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36841672</category>
   	  </item>
  <item>
   <title>New Study Finds XPERIENCE™ No Rinse Solution Has Persistent Efficacy Against Both Planktonic Bacteria and Bacterial Biofilms</title>
   <link>http://www.streetinsider.com/Press+Releases/New+Study+Finds+XPERIENCE%E2%84%A2+No+Rinse+Solution+Has+Persistent+Efficacy+Against+Both+Planktonic+Bacteria+and+Bacterial+Biofilms/20046281.html</link>
   <description>si-local-file:///var/storage/newsbody/2022/0510/20046281.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/New+Study+Finds+XPERIENCE%E2%84%A2+No+Rinse+Solution+Has+Persistent+Efficacy+Against+Both+Planktonic+Bacteria+and+Bacterial+Biofilms/20046281.html</guid>
   <pubDate>Tue, 10 May 2022 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36841672</category>
   	  </item>
  <item>
   <title>New Study Finds XPERIENCE™ No Rinse Solution Has Persistent Efficacy Against Both Planktonic Bacteria and Bacterial Biofilms</title>
   <link>http://www.streetinsider.com/Business+Wire/New+Study+Finds+XPERIENCE%E2%84%A2+No+Rinse+Solution+Has+Persistent+Efficacy+Against+Both+Planktonic+Bacteria+and+Bacterial+Biofilms/20046281.html</link>
   <description>si-local-file:///var/storage/newsbody/2022/0510/20046281.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/New+Study+Finds+XPERIENCE%E2%84%A2+No+Rinse+Solution+Has+Persistent+Efficacy+Against+Both+Planktonic+Bacteria+and+Bacterial+Biofilms/20046281.html</guid>
   <pubDate>Tue, 10 May 2022 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.36841672</category>
   	  </item>
  <item>
   <title>Next Science to Exhibit Surgical Product Portfolio at AAOS 2021</title>
   <link>http://www.streetinsider.com/Press+Releases/Next+Science+to+Exhibit+Surgical+Product+Portfolio+at+AAOS+2021/18856898.html</link>
   <description>si-local-file:///var/storage/newsbody/2021/0824/18856898.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Next+Science+to+Exhibit+Surgical+Product+Portfolio+at+AAOS+2021/18856898.html</guid>
   <pubDate>Tue, 24 Aug 2021 12:11:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06558597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.18980905</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26590772</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXS</category>
   	  </item>
  <item>
   <title>Next Science to Exhibit Surgical Product Portfolio at AAOS 2021</title>
   <link>http://www.streetinsider.com/Business+Wire/Next+Science+to+Exhibit+Surgical+Product+Portfolio+at+AAOS+2021/18856898.html</link>
   <description>si-local-file:///var/storage/newsbody/2021/0824/18856898.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Next+Science+to+Exhibit+Surgical+Product+Portfolio+at+AAOS+2021/18856898.html</guid>
   <pubDate>Tue, 24 Aug 2021 12:11:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06558597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.18980905</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26590772</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXS</category>
   	  </item>
  <item>
   <title>Next Science to Exhibit Surgical Product Portfolio at AAOS 2021</title>
   <link>http://www.streetinsider.com/Press+Releases/Next+Science+to+Exhibit+Surgical+Product+Portfolio+at+AAOS+2021/18856898.html</link>
   <description>si-local-file:///var/storage/newsbody/2021/0824/18856898.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Next+Science+to+Exhibit+Surgical+Product+Portfolio+at+AAOS+2021/18856898.html</guid>
   <pubDate>Tue, 24 Aug 2021 12:11:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06558597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.18980905</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26590772</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXS</category>
   	  </item>
  <item>
   <title>Next Science to Exhibit Surgical Product Portfolio at AAOS 2021</title>
   <link>http://www.streetinsider.com/Business+Wire/Next+Science+to+Exhibit+Surgical+Product+Portfolio+at+AAOS+2021/18856898.html</link>
   <description>si-local-file:///var/storage/newsbody/2021/0824/18856898.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Next+Science+to+Exhibit+Surgical+Product+Portfolio+at+AAOS+2021/18856898.html</guid>
   <pubDate>Tue, 24 Aug 2021 12:11:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06558597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.18980905</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26590772</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXS</category>
   	  </item>
  <item>
   <title>Next Science to Exhibit Surgical Product Portfolio at AAOS 2021</title>
   <link>http://www.streetinsider.com/Press+Releases/Next+Science+to+Exhibit+Surgical+Product+Portfolio+at+AAOS+2021/18856898.html</link>
   <description>si-local-file:///var/storage/newsbody/2021/0824/18856898.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Next+Science+to+Exhibit+Surgical+Product+Portfolio+at+AAOS+2021/18856898.html</guid>
   <pubDate>Tue, 24 Aug 2021 12:11:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06558597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.18980905</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26590772</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXS</category>
   	  </item>
  <item>
   <title>Next Science to Exhibit Surgical Product Portfolio at AAOS 2021</title>
   <link>http://www.streetinsider.com/Business+Wire/Next+Science+to+Exhibit+Surgical+Product+Portfolio+at+AAOS+2021/18856898.html</link>
   <description>si-local-file:///var/storage/newsbody/2021/0824/18856898.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Next+Science+to+Exhibit+Surgical+Product+Portfolio+at+AAOS+2021/18856898.html</guid>
   <pubDate>Tue, 24 Aug 2021 12:11:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06558597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.18980905</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26590772</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXS</category>
   	  </item>
  <item>
   <title>Next Science to Exhibit Surgical Product Portfolio at AAOS 2021</title>
   <link>http://www.streetinsider.com/Press+Releases/Next+Science+to+Exhibit+Surgical+Product+Portfolio+at+AAOS+2021/18856898.html</link>
   <description>si-local-file:///var/storage/newsbody/2021/0824/18856898.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Next+Science+to+Exhibit+Surgical+Product+Portfolio+at+AAOS+2021/18856898.html</guid>
   <pubDate>Tue, 24 Aug 2021 12:11:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06558597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.18980905</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26590772</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXS</category>
   	  </item>
  <item>
   <title>Next Science to Exhibit Surgical Product Portfolio at AAOS 2021</title>
   <link>http://www.streetinsider.com/Business+Wire/Next+Science+to+Exhibit+Surgical+Product+Portfolio+at+AAOS+2021/18856898.html</link>
   <description>si-local-file:///var/storage/newsbody/2021/0824/18856898.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Next+Science+to+Exhibit+Surgical+Product+Portfolio+at+AAOS+2021/18856898.html</guid>
   <pubDate>Tue, 24 Aug 2021 12:11:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06558597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.18980905</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26590772</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXS</category>
   	  </item>
  <item>
   <title>Next Science Begins U.S. Clinical Trial for XPERIENCE No Rinse Antimicrobial Solution</title>
   <link>http://www.streetinsider.com/Press+Releases/Next+Science+Begins+U.S.+Clinical+Trial+for+XPERIENCE+No+Rinse+Antimicrobial+Solution/18802845.html</link>
   <description>si-local-file:///var/storage/newsbody/2021/0811/18802845.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Next+Science+Begins+U.S.+Clinical+Trial+for+XPERIENCE+No+Rinse+Antimicrobial+Solution/18802845.html</guid>
   <pubDate>Wed, 11 Aug 2021 11:54:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06558597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37036683</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXS</category>
   	  </item>
  <item>
   <title>Next Science Begins U.S. Clinical Trial for XPERIENCE No Rinse Antimicrobial Solution</title>
   <link>http://www.streetinsider.com/Business+Wire/Next+Science+Begins+U.S.+Clinical+Trial+for+XPERIENCE+No+Rinse+Antimicrobial+Solution/18802845.html</link>
   <description>si-local-file:///var/storage/newsbody/2021/0811/18802845.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Next+Science+Begins+U.S.+Clinical+Trial+for+XPERIENCE+No+Rinse+Antimicrobial+Solution/18802845.html</guid>
   <pubDate>Wed, 11 Aug 2021 11:54:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06558597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37036683</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXS</category>
   	  </item>
  <item>
   <title>Next Science Begins U.S. Clinical Trial for XPERIENCE No Rinse Antimicrobial Solution</title>
   <link>http://www.streetinsider.com/Press+Releases/Next+Science+Begins+U.S.+Clinical+Trial+for+XPERIENCE+No+Rinse+Antimicrobial+Solution/18802845.html</link>
   <description>si-local-file:///var/storage/newsbody/2021/0811/18802845.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Next+Science+Begins+U.S.+Clinical+Trial+for+XPERIENCE+No+Rinse+Antimicrobial+Solution/18802845.html</guid>
   <pubDate>Wed, 11 Aug 2021 11:54:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06558597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37036683</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXS</category>
   	  </item>
  <item>
   <title>Next Science Begins U.S. Clinical Trial for XPERIENCE No Rinse Antimicrobial Solution</title>
   <link>http://www.streetinsider.com/Business+Wire/Next+Science+Begins+U.S.+Clinical+Trial+for+XPERIENCE+No+Rinse+Antimicrobial+Solution/18802845.html</link>
   <description>si-local-file:///var/storage/newsbody/2021/0811/18802845.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Next+Science+Begins+U.S.+Clinical+Trial+for+XPERIENCE+No+Rinse+Antimicrobial+Solution/18802845.html</guid>
   <pubDate>Wed, 11 Aug 2021 11:54:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06558597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37036683</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXS</category>
   	  </item>
  <item>
   <title>Next Science Begins U.S. Clinical Trial for XPERIENCE No Rinse Antimicrobial Solution</title>
   <link>http://www.streetinsider.com/Press+Releases/Next+Science+Begins+U.S.+Clinical+Trial+for+XPERIENCE+No+Rinse+Antimicrobial+Solution/18802845.html</link>
   <description>si-local-file:///var/storage/newsbody/2021/0811/18802845.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Next+Science+Begins+U.S.+Clinical+Trial+for+XPERIENCE+No+Rinse+Antimicrobial+Solution/18802845.html</guid>
   <pubDate>Wed, 11 Aug 2021 11:54:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06558597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37036683</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXS</category>
   	  </item>
  <item>
   <title>Next Science Begins U.S. Clinical Trial for XPERIENCE No Rinse Antimicrobial Solution</title>
   <link>http://www.streetinsider.com/Business+Wire/Next+Science+Begins+U.S.+Clinical+Trial+for+XPERIENCE+No+Rinse+Antimicrobial+Solution/18802845.html</link>
   <description>si-local-file:///var/storage/newsbody/2021/0811/18802845.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Next+Science+Begins+U.S.+Clinical+Trial+for+XPERIENCE+No+Rinse+Antimicrobial+Solution/18802845.html</guid>
   <pubDate>Wed, 11 Aug 2021 11:54:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06558597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37036683</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXS</category>
   	  </item>
 </channel>
</rss>
